Literature DB >> 24957131

Glomerular disease: The search goes on: suPAR is not the elusive FSGS factor.

Jeroen K Deegens1, Jack F Wetzels1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24957131     DOI： 10.1038/nrneph.2014.113

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  10 in total

1.  Successful transplant of a kidney with focal segmental glomerulosclerosis.

Authors:  R Rea; C Smith; K Sandhu; J Kwan; C Tomson
Journal:  Nephrol Dial Transplant       Date:  2001-02       Impact factor: 5.992

2.  Are serum suPAR determinations by current ELISA methodology reliable diagnostic biomarkers for FSGS?

Authors:  Detlef Schlöndorff
Journal:  Kidney Int       Date:  2014-03       Impact factor: 10.612

3.  The soluble urokinase receptor is not a clinical marker for focal segmental glomerulosclerosis.

Authors:  Björn Meijers; Rutger J H Maas; Ben Sprangers; Kathleen Claes; Ruben Poesen; Bert Bammens; Maarten Naesens; Jeroen K J Deegens; Ruth Dietrich; Markus Storr; Jack F M Wetzels; Pieter Evenepoel; Dirk Kuypers
Journal:  Kidney Int       Date:  2014-01-08       Impact factor: 10.612

4.  Immunosuppressive treatment of focal segmental glomerulosclerosis: lessons from a randomized controlled trial.

Authors:  Jeroen K J Deegens; Jack F M Wetzels
Journal:  Kidney Int       Date:  2011-10       Impact factor: 10.612

5.  Serum soluble urokinase-type plasminogen activator receptor levels and idiopathic FSGS in children: a single-center report.

Authors:  Margret E Bock; Heather E Price; Lorenzo Gallon; Craig B Langman
Journal:  Clin J Am Soc Nephrol       Date:  2013-04-25       Impact factor: 8.237

6.  Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis.

Authors:  Changli Wei; Shafic El Hindi; Jing Li; Alessia Fornoni; Nelson Goes; Junichiro Sageshima; Dony Maiguel; S Ananth Karumanchi; Hui-Kim Yap; Moin Saleem; Qingyin Zhang; Boris Nikolic; Abanti Chaudhuri; Pirouz Daftarian; Eduardo Salido; Armando Torres; Moro Salifu; Minnie M Sarwal; Franz Schaefer; Christian Morath; Vedat Schwenger; Martin Zeier; Vineet Gupta; David Roth; Maria Pia Rastaldi; George Burke; Phillip Ruiz; Jochen Reiser
Journal:  Nat Med       Date:  2011-07-31       Impact factor: 53.440

7.  Administration of recombinant soluble urokinase receptor per se is not sufficient to induce podocyte alterations and proteinuria in mice.

Authors:  Dominique Cathelin; Sandrine Placier; Michael Ploug; Marie-Christine Verpont; Sophie Vandermeersch; Yosu Luque; Alexandre Hertig; Eric Rondeau; Laurent Mesnard
Journal:  J Am Soc Nephrol       Date:  2014-05-01       Impact factor: 10.121

Review 8.  Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis.

Authors:  Ellen T McCarthy; Mukut Sharma; Virginia J Savin
Journal:  Clin J Am Soc Nephrol       Date:  2010-10-21       Impact factor: 8.237

Review 9.  Serum suPAR in patients with FSGS: trash or treasure?

Authors:  Rutger J H Maas; Jeroen K J Deegens; Jack F M Wetzels
Journal:  Pediatr Nephrol       Date:  2013-03-21       Impact factor: 3.714

10.  Modification of kidney barrier function by the urokinase receptor.

Authors:  Changli Wei; Clemens C Möller; Mehmet M Altintas; Jing Li; Karin Schwarz; Serena Zacchigna; Liang Xie; Anna Henger; Holger Schmid; Maria P Rastaldi; Peter Cowan; Matthias Kretzler; Roberto Parrilla; Moïse Bendayan; Vineet Gupta; Boris Nikolic; Raghu Kalluri; Peter Carmeliet; Peter Mundel; Jochen Reiser
Journal:  Nat Med       Date:  2007-12-16       Impact factor: 53.440
  10 in total
  7 in total

1.  Reply: Measurement of serum suPAR is not ready for clinical use.

Authors:  Jeroen Deegens; Jack Wetzels
Journal:  Nat Rev Nephrol       Date:  2014-08-26       Impact factor: 28.314

2.  suPAR is the circulating factor in some but not all FSGS.

Authors:  Howard Trachtman; Jochen Reiser
Journal:  Nat Rev Nephrol       Date:  2014-08-26       Impact factor: 28.314

3.  Plasma Soluble Urokinase Receptor Level Is Correlated with Podocytes Damage in Patients with IgA Nephropathy.

Authors:  Yanfeng Zhao; Lijun Liu; Jing Huang; Sufang Shi; Jicheng Lv; Gang Liu; Minghui Zhao; Hong Zhang
Journal:  PLoS One       Date:  2015-07-13       Impact factor: 3.240

Review 4.  The glomerular permeability factors in idiopathic nephrotic syndrome.

Authors:  Jean-Claude Davin
Journal:  Pediatr Nephrol       Date:  2015-04-30       Impact factor: 3.714

5.  Serum C3 and Renal Outcome in Patients with Primary Focal Segmental Glomerulosclerosis.

Authors:  Jian Liu; Jingyuan Xie; Xiaoyan Zhang; Jun Tong; Xu Hao; Hong Ren; Weiming Wang; Nan Chen
Journal:  Sci Rep       Date:  2017-06-22       Impact factor: 4.379

6.  Soluble Urokinase Receptor Levels Are Correlated with Focal Segmental Glomerulosclerosis Lesions in IgA Nephropathy: A Cohort Study from China.

Authors:  Shui-Ming Guo; Min Han; Mei-Xue Chen; Yong Ning; Guang-Chang Pei; Yue-Qiang Li; Wei Dai; Shu-Wang Ge; Yuan-Jun Deng; Yan-Yan Guo; Xiao-Qing Li; Hermann Haller; Gang Xu; Song Rong
Journal:  PLoS One       Date:  2015-09-18       Impact factor: 3.240

7.  Patients With Combined Membranous Nephropathy and Focal Segmental Glomerulosclerosis Have Comparable Clinical and Autoantibody Profiles With Primary Membranous Nephropathy: A Retrospective Observational Study.

Authors:  Qiu-Hua Gu; Zhao Cui; Jing Huang; Yi-Miao Zhang; Zhen Qu; Fang Wang; Xin Wang; Su-Xia Wang; Gang Liu; Ming-Hui Zhao
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.